Research progress on the relationship between oral microbes and digestive system diseases

doi:10.7518/hxkq.2018.03.019

Abstract

Abstract:

The human microbiome project promoted further understanding on human oral microbes. Besides oral diseases such as dental caries, periodontal disease, and oral cancer, oral microbes are closely associated with systematic diseases. They have a close connection with digestive system diseases and even contribute to the origination and progression of colorectal cancer. By reviewing recent studies involving oral microbe-related digestive systemic diseases, we aim to propose the con-siderable role of oral microbes in relation to digestive systemic diseases and the way of oral microbes to multiple organs of digestive system.

Key words: oral microbes, oral microbiota, digestive system disease, microbiome

CLC Number:

R780.2

Bolei Li, Lei Cheng, Xuedong Zhou, Xian Peng. Research progress on the relationship between oral microbes and digestive system diseases[J]. West China Journal of Stomatology, 2018, 36(3): 331-335.

References 45

[1]	Aas JA, Paster BJ, Stokes LN, et al.Defining the normal bacterial flora of the oral cavity[J]. J Clin Microbiol, 2005, 43(11): 5721-5732.
[2]	Teng F, Yang F, Huang S, et al.Prediction of early childhood caries via spatial-temporal variations of oral microbiota[J]. Cell Host Microbe, 2015, 18(3): 296-306.
[3]	Hajishengallis G, Liang S, Payne MA, et al.Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement[J]. Cell Host Microbe, 2011, 10(5): 497-506.
[4]	Pushalkar S, Ji X, Li Y, et al.Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squa-mous cell carcinoma[J]. BMC Microbiol, 2012, 12: 144.
[5]	Hu X, Zhang Q, Hua H, et al.Changes in the salivary micro-biota of oral leukoplakia and oral cancer[J]. Oral Oncol, 2016, 56: e6-e8.
[6]	Gallimidi AB, Fischman S, Revach B, et al.Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model[J]. Oncotarget, 2015, 6(26): 22613-22623.
[7]	Zhang X, Zhang D, Jia H, et al.The oral and gut microbio-mes are perturbed in rheumatoid arthritis and partly norma-lized after treatment[J]. Nat Med, 2015, 21(8): 895-905.
[8]	Han YW.Oral health and adverse pregnancy outcomes- what’s next[J]. J Dent Res, 2011, 90(3): 289-293.
[9]	Han YW, Wang X.Mobile microbiome: oral bacteria in extra-oral infections and inflammation[J]. J Dent Res, 2013, 92(6): 485-491.
[10]	Chen X, Yuan Z, Lu M, et al.Poor oral health is associated with an increased risk of esophageal squamous cell carci-noma—a population-based case-control study in China[J]. Int J Cancer, 2017, 140(3): 626-635.
[11]	Nasrollahzadeh D, Malekzadeh R, Aghcheli K, et al.Gastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habit[J]. Br J Cancer, 2012, 107(5): 888-894.
[12]	Sepehr A, Kamangar F, Fahimi S, et al.Poor oral health as a risk factor for esophageal squamous dysplasia in northea-stern Iran[J]. Anticancer Res, 2005, 25(1B): 543-546.
[13]	Sato F, Oze I, Kawakita D, et al.Inverse association between toothbrushing and upper aerodigestive tract cancer risk in a Japanese population[J]. Head Neck, 2011, 33(11): 1628-1637.
[14]	Ahn J, Segers S, Hayes RB.Periodontal disease, Porphyro-monas gingivalis serum antibody levels and orodigestive cancer mortality[J]. Carcinogenesis, 2012, 33(5): 1055-1058.
[15]	Chen X, Winckler B, Lu M, et al.Oral microbiota and risk for esophageal squamous cell carcinoma in a high-risk area of China[J]. PLoS One, 2015, 10(12): e0143603.
[16]	Gao S, Li S, Ma Z, et al.Presence of Porphyromonas gin-givalis in esophagus and its association with the clinicopatho-logical characteristics and survival in patients with esopha-geal cancer[J]. Infect Agents Cancer, 2016, 11: 3.
[17]	Muto M, Hitomi Y, Ohtsu A, et al.Acetaldehyde production by non-pathogenic Neisseria in human oral microflora: imp-lications for carcinogenesis in upper aerodigestive tract[J]. Int J Cancer, 2000, 88(3): 342-350.
[18]	Fan X, Alekseyenko AV, Wu J, et al.Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study[J]. Gut, 2018, 67(1): 120-127.
[19]	Michaud DS, Joshipura K, Giovannucci E, et al.A prospec-tive study of periodontal disease and pancreatic cancer in US male health professionals[J]. J Natl Cancer Inst, 2007, 99(2): 171-175.
[20]	Chang JS, Tsai CR, Chen LT, et al.Investigating the asso-ciation between periodontal disease and risk of pancreatic cancer[J]. Pancreas, 2016, 45(1): 134-141.
[21]	Torres PJ, Fletcher EM, Gibbons SM, et al.Characterization of the salivary microbiome in patients with pancreatic cancer[J]. PeerJ, 2015, 3: e1373.
[22]	Michaud DS, Izard J, Wilhelm-Benartzi CS, et al.Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study[J]. Gut, 2013, 62(12): 1764-1770.
[23]	Atanasova KR, Yilmaz Ö.Prelude to oral microbes and chronic diseases: past, present and future[J]. Microb Infect, 2015, 17(7): 473-483.
[24]	Le Roy T, Llopis M, Lepage P, et al.Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice[J]. Gut, 2013, 62(12): 1787-1794.
[25]	Llopis M, Cassard AM, Wrzosek L, et al.Intestinal micro-biota contributes to individual susceptibility to alcoholic liver disease[J]. Gut, 2016, 65(5): 830-839.
[26]	Lu H, Ren Z, Li A, et al.Deep sequencing reveals microbiota dysbiosis of tongue coat in patients with liver carcinoma[J]. Sci Rep, 2016, 6: 33142.
[27]	Bajaj JS, Betrapally NS, Hylemon PB, et al.Salivary micro-biota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy[J]. Hepatology, 2015, 62(4): 1260-1271.
[28]	Qin N, Yang F, Li A, et al.Alterations of the human gut microbiome in liver cirrhosis[J]. Nature, 2014, 513(7516): 59-64.
[29]	Nakajima M, Arimatsu K, Kato T, et al.Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of entero-bacteria to the liver[J]. PLoS One, 2015, 10(7): e0134234.
[30]	Arimatsu K, Yamada H, Miyazawa H, et al.Oral pathobiont induces systemic inflammation and metabolic changes asso-ciated with alteration of gut microbiota[J]. Sci Rep, 2014, 4: 4828.
[31]	Seedorf H, Griffin NW, Ridaura VK, et al.Bacteria from diverse habitats colonize and compete in the mouse gut[J]. Cell, 2014, 159(2): 253-266.
[32]	Ray K.IBD. Gut microbiota in IBD goes viral[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(3): 122.
[33]	Said HS, Suda W, Nakagome S, et al.Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers[J]. DNA Res, 2014, 21(1): 15-25.
[34]	Ismail Y, Mahendran V, Octavia S, et al.Investigation of the enteric pathogenic potential of oral campylobacter con-cisus strains isolated from patients with inflammatory bowel disease[J]. PLoS One, 2012, 7(5): e38217.
[35]	Strauss J, Kaplan GG, Beck PL, et al.Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host[J]. Inflamm Bowel Dis, 2011, 17(9): 1971-1978.
[36]	Castellarin M, Warren RL, Freeman JD, et al.Fusobacterium nucleatum infection is prevalent in human colorectal car-cinoma[J]. Genome Res, 2012, 22(2): 299-306.
[37]	Kostic AD, Gevers D, Pedamallu CS, et al.Genomic analysis identifies association of Fusobacterium with colorectal car-cinoma[J]. Genome Res, 2012, 22(2): 292-298.
[38]	Chen W, Liu F, Ling Z, et al.Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer[J]. PLoS One, 2012, 7(6): e39743.
[39]	Rubinstein MR, Wang X, Liu W, et al.Fusobacterium nuclea-tum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin[J]. Cell Host Microbe, 2013, 14(2): 195-206.
[40]	Gur C, Ibrahim Y, Isaacson B, et al.Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack[J]. Immunity, 2015, 42(2): 344-355.
[41]	Kostic A, Chun E, Robertson L, et al.Fusobacterium nuclea-tum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment[J]. Cell Host Microbe, 2013, 14(2): 207-215.
[42]	Abed J, Emgård JM, Zamir G, et al.Fap2 mediates Fuso-bacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc[J]. Cell Host Microbe, 2016, 20(2): 215-225.
[43]	Kamada N, Seo SU, Chen GY, et al.Role of the gut micro-biota in immunity and inflammatory disease[J]. Nat Rev Immunol, 2013, 13(5): 321-335.
[44]	Turnbaugh PJ, Ridaura VK, Faith JJ, et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice[J]. Sci Transl Med, 2009, 1(6): 6ra14.
[45]	Arrieta MC, Walter J, Finlay BB.Human microbiota-asso-ciated mice: a model with challenges[J]. Cell Host Microbe, 2016, 19(5): 575-578.